本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apogee Therapeutics

81.16
-1.2700-1.54%
盘后81.160.00000.00%16:10 EDT
成交量:33.84万
成交额:2,766.08万
市值:61.15亿
市盈率:-18.78
高:84.12
开:82.43
低:81.03
收:82.43
52周最高:95.32
52周最低:34.34
股本:7,533.99万
流通股本:7,030.80万
量比:0.47
换手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-4.3206
每股收益(LYR):-4.2155
净资产收益率:-28.47%
总资产收益率:-19.01%
市净率:4.87
市盈率(LYR):-19.25

数据加载中...

2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/11

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/24

重要事件披露

Form 8-K - Current report
2026/04/08

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/25

重要事件披露

Form 8-K - Current report
2026/03/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/23

重要事件披露

Form 8-K - Current report
2026/03/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities